Alphavirus replicon particles expressing TRP2

Details for Australian Patent Application No. 2010234362 (hide)

Owner Sloan Kettering Institute For Cancer Research AlphaVax, Inc.

Inventors Wolchok, Jedd D.; Avogadri, Francesca; Olmsted, Robert A.; Maughan, Maureen

Agent Wrays

Pub. Number AU-A-2010234362

PCT Pub. Number WO2010/118252

Priority 61/167,774 08.04.09 US

Filing date 8 April 2010

Wipo publication date 14 October 2010

International Classifications

A01N 63/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/118252 Priority application(s): WO2010/118252

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234364-System and method for image compression

2010234360-Methods and compositions of PI-3 kinase inhibitors for treating fibrosis